三元生物 20251124 摘要 美国对赤藓糖醇征收高额预交关税（462%）导致直接出口受阻，但因 美国市场刚性需求和三仁生物品牌效应，产品通过转口贸易维持部分销 量，1-9 月美国市场销量同比下降 25%。 针对美国反倾销，部分客户提起诉讼，若法院裁定特定复配产品不在反 倾销范围内，将有助于合法出口。美国政府停摆导致裁决推迟，预计未 来一年内有结果，同时，企业积极探索通过邻国转口贸易。 欧盟对三仁生物征收较高反倾销税，导致直接出口停滞。公司通过调整 产品配方，生产含 90%以下阿洛酮糖的赤藓糖醇复配产品以规避关税， 并逐步被客户接受，需求量增加。 国内赤藓糖醇价格维持在每公斤 1.2-1.3 美元的底部水平，行业库存普 遍不大，企业多以销定产。公司虽主动降价促销，但通过扩大销量和成 本控制，基本维持了运营效果，预计 2025 年业绩与 2024 年相当。 公司通过技术改进、节能改造和自动化控制等措施降低生产成本，有效 应对欧美反倾销影响，同时积极拓展东南亚、中东和南美等新兴市场。 Q&A 今年前三季度，三仁生物在经营情况上有哪些变化？美国对行业的反倾销调查 进展如何，对公司业绩产生了哪些影响？ 欧盟对公司的 ...

投资者关系活动 类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 √现场参观 □其他 （请文字说明其他活动内容） 参与单位名称及 人员姓名 华创证券：申起昊 时间 2025 年 11 月 13 日 地点 公司宝应生产基地 上市公司接待人 员姓名 副总经理、董事会秘书 吴达明 证券事务部副部长 陈 旭 投资者关系活动 主要内容介绍 1、公司聚醚产能 1.9 万吨，宝应生产基地产能多少、主要原料 有哪些、主要产品有哪些？ 公司宝应生产基地聚醚产能为 9500 吨/年，主要原材料有环氧乙 烷、环氧丙烷、丙烯醇等，主要产品有烯丙基聚醚、聚醚多元醇、脂 肪醇聚醚、封端聚醚等，广泛应用于纺织、涂料、聚氨酯、农药、生 化、医药等领域。 2、宝应生产基地绝大部分厂房都很有年代感，为什么空中管廊 却很新？ 宝应生产基地自 1986 年开始建设，已有快 40 年的历史；根据《江 苏省应急管理厅关于印发＜本质安全诊断治理基本要求＞ 的通知》 （苏应急〔2019〕53 号）的要求，2020 年起，公司花费了近 5000 万元进行了升级改造，新建的管廊桥架是一个集安全、效率、经济、 环保和战略规划 ...

Core Viewpoint - The company reported its Q3 2025 results, showing a significant increase in revenue and profit in Q3, while facing challenges in the first three quarters of the year, leading to a decline in net profit year-over-year. Revenue Summary - For the first three quarters of 2025, the company achieved revenue of 3.024 billion yuan, a year-over-year increase of 12.7% [1] - In Q3 2025, revenue reached 1.186 billion yuan, representing a year-over-year growth of 33.3% and a quarter-over-quarter increase of 24.7% [3] - Revenue breakdown for Q3 includes: - Security and identification chips: 239 million yuan, up 16.0% YoY, up 25.8% QoQ - Non-volatile memory: 343 million yuan, up 44.1% YoY, up 69.0% QoQ - Smart meter chips: 139 million yuan, up 41.8% YoY, down 4.1% QoQ - FPGA and other products: 433 million yuan, up 34.5% YoY, up 17.7% QoQ - Testing services: 32 million yuan, up 23.1% YoY, down 30.4% QoQ [3] Profit Summary - The gross profit margin for the first three quarters was 58.47%, an increase of 3.42 percentage points year-over-year [2] - Net profit attributable to shareholders for the first three quarters was 330 million yuan, a decline of 22.69% YoY, while the non-GAAP net profit was 303 million yuan, down 21.21% YoY [2] - In Q3, net profit attributable to shareholders was 137 million yuan, a significant increase of 73.4% YoY and 140.4% QoQ, driven by revenue and gross profit growth [3] Product Development and Market Expansion - The company is actively expanding new products, with notable growth in FPGA and other product lines [1] - Key developments include: - Security and identification chips: Gaining market share through deep cooperation with Alipay - Non-volatile memory: Launching NOR Flash series for AMOLED modules and IoT modules - Smart meter chips: Inclusion of automotive-grade MCU products in customer platforms - FPGA and others: Advancements in large-scale FPGA and RF-FPGA production [4] Profit Forecast Adjustment - Due to impairment impacts, the company has adjusted its net profit forecasts for 2025-2027 to 645 million, 1.009 billion, and 1.285 billion yuan, respectively, down from previous estimates [4]

Core Viewpoint - The company has announced changes regarding its financial reporting and the use of raised funds, including the appointment of new auditors and the reallocation of surplus funds to enhance operational efficiency [6][34][46]. Financial Reporting - The board and management have confirmed the accuracy and completeness of the quarterly report, which has not been audited [2][3]. - The company has not made any retrospective adjustments or restatements to previous accounting data [3]. Auditor Changes - The company has appointed new signing auditors from KPMG Huazhen due to internal adjustments, with the new auditors being Wang Pu and Li Bingman [6][7]. Shareholder Meeting - The company will hold its third extraordinary general meeting on November 13, 2025, to discuss various proposals, including the reallocation of surplus funds [12][13][14]. Fund Utilization - The company plans to permanently supplement its working capital with surplus funds from completed projects, totaling approximately 27.62 million yuan [34][39]. - The surplus funds are primarily due to lower-than-expected transaction costs and effective cash management [37][38]. Project Changes - The company has revised the use of raised funds for new product development, shifting focus from the development of prothrombin complex to factor IX, while maintaining the overall budget for the project at 340.5 million yuan [46][47].

Investment Rating - The report maintains a "Recommended" rating for the company [5][11]. Core Insights - The company achieved a revenue of 203.18 million yuan in Q3 2025, representing a year-on-year growth of 20.61%, and a net profit attributable to shareholders of 67.43 million yuan, up 33.82% year-on-year [1]. - The growth in revenue is driven by the continuous expansion of overseas business, which accounted for 51.4% of total revenue in the first half of 2025, with a year-on-year growth of 30.7% [1]. - The company has established strong relationships with major clients such as Volkswagen, contributing to the growth of its overseas business [1]. - The gross margin for Q3 2025 was 55.2%, showing improvements both year-on-year and quarter-on-quarter, significantly higher than the average gross margin of 17.6% in the automotive parts industry [2]. - The company has increased its dividend payout ratio, with a total dividend amount of 74.45 million yuan for the first three quarters of 2025, representing 35.6% of the net profit attributable to shareholders [3]. - The company is actively developing new products using cold forging technology, expanding its material base to include aluminum, copper, titanium alloys, and stainless steel [3]. Summary by Sections Financial Performance - In Q3 2025, the company reported a revenue of 203.18 million yuan and a net profit of 67.43 million yuan, with respective year-on-year growth rates of 20.61% and 33.82% [1]. - The gross margin for Q3 2025 was 55.2%, an increase from 54.1% in Q2 2025 and 52.3% in Q3 2024 [2]. - The net profit margin for Q3 2025 was 34.4%, up from 31.7% in the same period last year [2]. Dividend Policy - The company announced a cash dividend of 2.50 yuan per 10 shares for Q3 2025, marking the second dividend distribution for the year [3]. - The dividend payout ratio has increased from around 30% in 2019-2022 to 57.6% in 2024 [3]. Growth Prospects - The company is expected to continue its growth trajectory, with projected net profits of 270.09 million yuan, 325.38 million yuan, and 391.87 million yuan for 2025, 2026, and 2027 respectively [4]. - The company is expanding into new product areas, including precision electromagnetic valves and electric drive transmission systems, which are anticipated to support long-term growth [3].

Core Viewpoint - The company is actively tracking industry technology trends and market demand changes, focusing on the development and research of new products [1] Group 1 - The company is committed to closely monitoring industry technology trends [1] - The company is responsive to changes in market demand [1] - The company is engaged in the development and research of new products [1]

Core Viewpoint - Youfa Group (601686) reported explosive growth in its financial performance for Q3 and the first three quarters of 2025, with significant increases in revenue and net profit [1] Financial Performance - In Q3, the company achieved operating revenue of 13.104 billion yuan and a net profit of 215 million yuan, representing a year-on-year increase of 2320.53% [1] - For the first three quarters, the company reported operating revenue of 37.992 billion yuan and a net profit of 502 million yuan, a staggering year-on-year increase of 399.25% [1] - The company's net profit after deducting non-recurring items reached 415 million yuan, soaring by 1309.9% year-on-year [1] - As of September this year, total assets amounted to 26.743 billion yuan, with net assets attributable to shareholders reaching 6.911 billion yuan, indicating strong financial stability [1] Growth Drivers - The significant growth in performance is attributed to increased sales volume and improved product gross margins, which are the core drivers of net profit growth [1] - The company has enhanced cost control and operational efficiency through optimized supply chain collaboration and cost-reduction strategies, further increasing profitability [1] - Accelerated new product development and market expansion, including JCOE process oil and gas transmission pipes and high-end precision steel pipes, have strengthened the company's competitiveness [1] Strategic Initiatives - Youfa Group plans to continue implementing its "three-year action" plan to improve domestic and international capacity layout, including the construction of bases in Chengdu, Sichuan [1] - The company aims to accelerate its expansion into overseas markets while reinforcing terminal operations, optimizing inventory management, and employing hedging strategies to cope with market fluctuations, thereby consolidating its leading position in the industry [1][2]

每经AI快讯，有投资者在投资者互动平台提问：公司全资子公司山东新蔚源新材料有限公司前段时间 开始试生产，目前生产状况如何了，是否顺利？目前生产的产品主要有哪些？ 海科新源（301292.SZ）10月20日在投资者互动平台表示，公司2025年加快推进新蔚源中试孵化基地落 地，持续孵化新产品丰富产品线，目前已有序安排试生产。公司将严格按照法律法规及监管要求履行信 息披露义务，相关研发方向及阶段性进展会在定期报告中依法披露。 （记者 王瀚黎） ...

Core Viewpoint - The semi-annual report performance meets expectations, with domestic business showing recovery growth and overseas business continuing rapid growth. Profit growth outpaces revenue growth primarily due to internal cost reduction and efficiency improvement, leading to a steady enhancement in profitability [1] Financial Performance - In the first half of the year, the company achieved revenue of 488 million yuan, a year-on-year increase of 28.27%, and a net profit attributable to the parent company of 114 million yuan, a year-on-year increase of 44.85%. The net profit after deducting non-recurring items was 106 million yuan, a year-on-year increase of 61.09% [2] - The basic earnings per share were 0.30 yuan per share [3] Quarterly Analysis - In Q2, the company achieved revenue of 258 million yuan, a year-on-year increase of 62.85% and a quarter-on-quarter increase of 12.14%. The net profit attributable to the parent company was 56 million yuan, a year-on-year increase of 136.70% [4] - The profit growth rate exceeded the revenue growth rate due to internal cost reduction and efficiency improvements. The company recorded credit impairment losses and asset impairment losses of 39.33 million yuan in the first half, compared to 11.02 million yuan in the same period last year [4] Outlook for the Second Half - The domestic business is expected to continue its recovery growth, while overseas business is anticipated to maintain rapid growth. The impact of joint procurement price reductions is expected to be cleared, and the company is likely to sustain high growth trends in Q3 and Q4 due to low performance baselines from the previous year [5] Profitability and Cost Management - The gross profit margin decreased to 67.09%, down 4.43 percentage points, mainly due to price reductions from joint procurement. The sales expense ratio decreased significantly to 19.74%, down 9.59 percentage points, attributed to reduced market development costs [6] - The net cash flow from operating activities was 141 million yuan, compared to a negative 69 million yuan in the same period last year, mainly due to increased customer payments. The accounts receivable turnover days decreased to 88.8 days, down 90.1 days year-on-year, indicating improved collection efficiency [6] Long-term Growth Potential - In the short term, the company is expected to reach a performance inflection point, with overseas business likely to continue expanding. The company has strong R&D and production capabilities, with new products in sports medicine, robotics, and dentistry expected to contribute to future growth [7] - Revenue projections for 2025-2027 are 1.111 billion yuan, 1.302 billion yuan, and 1.529 billion yuan, representing year-on-year growth of 37.9%, 17.2%, and 17.4% respectively. Net profit attributable to the parent company is projected to be 238 million yuan, 280 million yuan, and 331 million yuan, with year-on-year growth of 90.8%, 17.4%, and 18.2% respectively [7]

Core Insights - The company reported strong financial performance for H1 2025, with significant year-on-year growth in revenue and net profit [1][2][4] Financial Performance - For H1 2025, the company achieved revenue of 8.497 billion, a year-on-year increase of 37.80%; net profit attributable to shareholders was 1.293 billion, up 45.71%; and net profit excluding non-recurring items was 1.236 billion, an increase of 47.04% [1] - In Q2 2025, revenue reached 5.270 billion, reflecting a year-on-year growth of 50.21%; net profit attributable to shareholders was 846 million, up 61.53%; and net profit excluding non-recurring items was 799 million, an increase of 59.97% [1] Profitability - The company's gross profit margin for H1 2025 was 31.74%, remaining stable year-on-year; the net profit margin was 15.64%, an increase of 1.1 percentage points [2] - In Q2 2025, the gross profit margin was 32.61%, up 0.07 percentage points year-on-year; the net profit margin was 16.43%, an increase of 1.18 percentage points [2] Inventory and Market Strategy - The company increased its inventory to 4.715 billion for H1 2025, a year-on-year rise of 35.61%, primarily due to increased orders [2] - The company is preparing for a delivery peak in the second half of the year by actively stocking up [2] International Market Performance - In H1 2025, overseas revenue reached 2.862 billion, a year-on-year increase of 88.91%, with international sales accounting for 33.68% of total revenue, a record high [3] - The gross profit margin for overseas markets was 35.69%, up 1.87 percentage points year-on-year [3] - The company has identified significant opportunities for infrastructure upgrades in developed regions and new construction in underdeveloped areas [3] New Product Development - The automotive electronics segment generated revenue of 45.45 million in H1 2025, a year-on-year increase of 216.58% [4] - The company is focusing on expanding its product offerings in automotive electronics and flexible direct current transmission [4] Future Outlook - The company is expected to benefit from ongoing domestic and international grid construction, with projected revenues of 20.26 billion, 24.81 billion, and 30.09 billion for 2025, 2026, and 2027, respectively, representing year-on-year growth of 31%, 22.5%, and 21.3% [4] - Net profit forecasts for the same years are 2.65 billion, 3.43 billion, and 4.07 billion, with expected growth rates of 29.5%, 29.2%, and 18.9% [4] - The current stock price corresponds to a PE ratio of 30, 23, and 20 for 2025, 2026, and 2027, respectively, maintaining a "buy" rating [4]